Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Fusion Pharmaceuticals
Fusion Pharmaceuticals
Among 2024’s modest M&A action, cancer, immunology and neuroscience deals trickle in
Pharma Voice
Thu, 11/7/24 - 11:12 am
M&A
Vertex Pharmacuticals
Alpine Immune Sciences
Eli Lilly
Morphic
Novartis
MorphoSys
Mariana Oncology
AstraZeneca
Fusion Pharmaceuticals
Lundbeck
Longboard Pharmaceuticals
AbbVie
Aliada Therapeutics
Biopharma M&A activity jumped 71% in Q1 2024
Medical Marketing and Media
Thu, 05/16/24 - 11:37 am
M&A
Novo Nordisk
Catalent
Gilead Sciences
CymaBay Therapeutics
AstraZeneca
Fusion Pharmaceuticals
JNJ
Ambrx
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
oncology
M&A
AbbVie
Immunogen
Bristol Myers Squibb
Mirati Therapeutics
RayzeBio
Novartis
MorphoSys
AstraZeneca
Fusion Pharmaceuticals
JNJ
Ambrx
Gracell
Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Fierce Biotech
Wed, 04/3/24 - 11:36 am
biotech
M&A
IPOs
CG Oncology
Kyverna Therapeutics
Contineum Therapeutics
Boundless Bio
CymaBay Therapeutics
Gilead Sciences
MorphoSys
Novartis
Fusion Pharmaceuticals
AstraZeneca
Ambryx
JNJ
Inhibrix
Aventis
AstraZeneca scoops up Fusion Pharmaceuticals in $2.4B radiopharma deal
Medical Marketing and Media
Tue, 03/19/24 - 11:58 am
AstraZeneca
Fusion Pharmaceuticals
M&A
radiopharmaceuticals
Fusion doses first subject in Phase I/II solid tumor therapy trial
Clinical Trials Arena
Tue, 08/30/22 - 11:53 am
Fusion Pharmaceuticals
solid tumors
clinical trials
FPI-1966
Fusion Pharma teams up with AstraZeneca in next-gen radiopharmaceuticals for cancer
Seeking Alpha
Mon, 11/2/20 - 10:33 am
AstraZeneca
Fusion Pharmaceuticals
radiopharmaceuticals
cancer
What pandemic? Biotech floats break records
EP Vantage
Wed, 07/8/20 - 10:37 am
biotech
IPOs
ADC Therapeutics
Akouos
Applied Molecular Transport
Avidity Biosciences
Ayala Pharmaceuticals
Forma Therapeutics
Fusion Pharmaceuticals
Generation Bio
Hyloris Pharmaceuticals
Lantern Pharma
ORIC Pharmaceuticals
Pliant Therapeutics
PolyPid
Repare Therapeutics
Royalty Pharma
SutroVax
Another day, another $100M-plus biotech megaround as radiopharmaceuticals’ popularity grows
Endpoints
Tue, 04/2/19 - 12:20 pm
Fusion Pharmaceuticals
radiopharmaceuticals
Novartis